This study was begin from January to December 2020 , to learn where there breast cancer and toxoplasma infection are related By used immunology test results . 2020, to know the association between Toxoplasma infection and breast cancer .by examine immunological test.32 women who had tumors were the subjects of a study conducted at the Al-Sadder Teaching Hospital in Al-Najaf Al-Ashraf , with breast tumor symptom . the mean age of women from 35-45 years ago . X-ray was done at first and sonar to detected the site of tumor and size . Biopsy was taken and sent to the Al- kafeel histopathological laboratory for making block and stain with hemaxlin and eoxin typical Histological change and ductal cancer show with irregular shape of duct mammary gland ,by use H & E method , serological was applied for toxoplasma appear in Five women is positive test for Toxoplasma AB by used special kit . the rest women consider control group . this study was find significant Toxoplasma associated with breast cancer , the case record at first time in Al-Najaf government.

Background and objectives: Breast cancer is a heterogeneous disease with variations in clinical behavior and biological features that lead to variations in response to treatments and survival. The aim of this study was to look for the histopathological and therapeutic factors associated with breast cancer recurrence. Methods: In this retrospective study, 100 locally recurrent or distant metastatic breast cancer cases were reviewed between 2008 -2016 at Rizgary Oncology Center in Erbil to find out the most important risk factors that have an effect on breast cancer recurrence. Results: The current study revealed that grade of disease has a great effect on breast cancer recurrence when 64.9% of patients with grade III disease have had disease recurrence within the first 2 years from the date of diagnosis. Also, this study showed that, within the first two years from the date of diagnosis, 57.9% of stage III cases have had disease recurrence. Adding more, within the first two years, 36.4% of the triple-negative subtype and 41% of human epidermal growth factor receptor 2 enriched subtypes had disease recurrence within that period. Concerning the effect of delay in receiving adjuvant radiotherapy, 65.2% of those patients that were waited for more than two months to receive adjuvant radiotherapy had disease recurrence within the first two years. Conclusions: Several factors have important effects on the disease recurrence like stage of the disease, grade, molecular subtypes, and delays in receiving adjuvant radiotherapy. All of them are independently causing earlier recurrence of breast cancer.